Investigation of inclusion complex of cilnidipine with hydroxypropyl- β-cyclodextrin

Carbohydrate Polymers

Volumn 90, Issue 4, 2012, Pages 1719-1724

  Hu, Liandong ^a   Zhang, Hailei ^a   Song, Weihua ^a   Gu, Deliang ^a   Hu, Qiaofeng ^a  

^a HEBEI UNIVERSITY   (China)

Author keywords

Characterization; Cilnidipine; HP CD; Inclusion complex; Photostability

Indexed keywords

CD COMPLEX; CILNIDIPINE; DISSOLUTION RATES; FOURIER; H NMR SPECTROSCOPY; INCLUSION COMPLEX; PHARMACEUTICAL APPLICATIONS; PHOTO-STABILITY; POWDER X-RAY DIFFRACTION (PXRD); STABILITY CONSTANTS; ULTRA VIOLET-VISIBLE; WATER SOLUBILITIES;

CHARACTERIZATION; DIFFERENTIAL SCANNING CALORIMETRY; FOURIER TRANSFORMS; SOLUBILITY; X RAY DIFFRACTION;

NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

2 HYDROXYPROPYL BETA CYCLODEXTRIN; 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; CILNIDIPINE; DIHYDROPYRIDINE DERIVATIVE;

ARTICLE; CHEMISTRY; DIFFERENTIAL SCANNING CALORIMETRY; INFRARED SPECTROSCOPY; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOTOCHEMISTRY; SOLUBILITY; X RAY DIFFRACTION;

BETA-CYCLODEXTRINS; CALORIMETRY, DIFFERENTIAL SCANNING; DIHYDROPYRIDINES; MAGNETIC RESONANCE SPECTROSCOPY; PHOTOCHEMISTRY; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 84865676048     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2012.07.057     Document Type: Article

References (25)

1. H. Boudad, P. Legrand, G. Lebas, M. Cheron, D. Duchene, and G. Ponchel Combined hydroxypropyl-β-cyclodextrin and poly (alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir International Journal of Pharmaceutics 218 1 2001 113 124
2. W. Chen, L.J. Yang, S.X. Ma, X.D. Yang, B.M. Fan, and J. Lin Crassicauline A/[beta]-cyclodextrin host-guest system: Preparation, characterization, inclusion mode, solubilization and stability Carbohydrate Polymers 84 4 2011 1321 1328
3. D.R. de Araujo, S.S. Tsuneda, C. Cereda, F. Del Gf Carvalho, P.S.C. Prete, and S.A. Fernandes Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-[beta]-cyclodextrin inclusion complex European Journal of Pharmaceutical Sciences 33 1 2008 60 71
4. M.V.G. De Araujo, E.K.B. Vieira, G.S. Lazaro, L. de Souza Conegero, O.P. Ferreira, and L.I.E. Almeida Inclusion complexes of pyrimethamine in 2-hydroxypropyl-[beta]-cyclodextrin: Characterization, phase solubility and molecular modelling Bioorganic and Medicinal Chemistry 15 17 2007 5752 5759
5. T. Higuchi, and K.A. Connors Phase solubility techniques 1965 Interscience New York
6. T. Kai, and Y. Kuzumoto Effects of a dual L/N-type calcium channel blocker cilnidipine on blood pressure, pulse rate, and autonomic functions in patients with mild to moderate hypertension Clinical and Experimental Hypertension 31 7 2009 595 604
7. J.H. Kim, S.K. Lee, M.H. Ki, W.K. Choi, S.K. Ahn, and H.J. Shin Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-β-cyclodextrin International Journal of Pharmaceutics 272 1 2004 79 89
8. Y. Kitahara, F. Saito, M. Akao, H. Fujita, A. Takahashi, and H. Taguchi Effect of morning and bedtime dosing with cilnidipine on blood pressure, heart rate, and sympathetic nervous activity in essential hypertensive patients Journal of Cardiovascular Pharmacology 43 1 2004 68 73
9. S. Kojima, M. Shida, and H. Yokoyama Comparison between cilnidipine and amlodipine besilate with respect to proteinuria in hypertensive patients with renal diseases Hypertension Research 27 6 2004 379 385
10. T. Konda, A. Enomoto, A. Takahara, and H. Yamamoto Effects of L/N-type calcium channel antagonist, cilnidipine on progressive renal injuries in Dahl salt-sensitive rats Biological and Pharmaceutical Bulletin 29 5 2006 933 937
11. J. Li, and X.J. Loh Cyclodextrin-based supramolecular architectures: Syntheses, structures, and applications for drug and gene delivery Advanced Drug Delivery Reviews 60 9 2008 1000 1017
12. L. Liu, and S. Zhu Preparation and characterization of inclusion complexes of prazosin hydrochloride with β-cyclodextrin and hydroxypropyl-β-cyclodextrin Journal of Pharmaceutical and Biomedical Analysis 40 1 2006 122 127
13. T. Loftsson, and M.E. Brewster Pharmaceutical applications of cyclodextrins. I. Drug solubilization and stabilization Journal of Pharmaceutical Sciences 85 10 1996 1017 1025
14. L.A. Miller, R.L. Carrier, and I. Ahmed Practical considerations in development of solid dosage forms that contain cyclodextrin Journal of Pharmaceutical Sciences 96 7 2007 1691 1707
15. J. Minami, T. Ishimitsu, T. Higashi, A. Numabe, and H. Matsuoka Comparison between cilnidipine and nisoldipine with respect to effects on blood pressure and heart rate in hypertensive patients Hypertension Research 21 3 1998 215 219
16. J. Minami, T. Ishimitsu, Y. Kawano, A. Numabe, and H. Matsuoka Comparison of 24-hour blood pressure, heart rate, and autonomic nerve activity in hypertensive patients treated with cilnidipine or nifedipine retard Journal of Cardiovascular Pharmacology 32 2 1998 331 336
17. J. Minami, Y. Kawano, Y. Makino, H. Matsuoka, and S. Takishita Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension British Journal of Clinical Pharmacology 50 6 2000 615 620
18. W. Misiuk, and M. Zalewska Investigation of inclusion complex of trazodone hydrochloride with hydroxypropyl-[beta]-cyclodextrin Carbohydrate Polymers 77 3 2009 482 488
19. S. Morimoto, Y. Yano, K. Maki, and T. Iwasaka Renal and vascular protective effects of cilnidipine in patients with essential hypertension Journal of Hypertension 25 10 2007 2178 2183
20. S. Narita, Y. Yoshioka, A. Ide, T. Kadokami, H. Momii, and M. Yoshida Effects of the L/N-type calcium channel antagonist cilnidipine on morning blood pressure control and peripheral edema formation Journal of the American Society of Hypertension 5 5 2011 410 416
21. J. Szejtli Introduction and general overview of cyclodextrin chemistry Chemical Reviews 98 5 1998 1743 1754
22. S. Tommasini, M.L. Calabro, R. Stancanelli, P. Donato, C. Costa, and S. Catania The inclusion complexes of hesperetin and its 7-rhamnoglucoside with (2-hydroxypropyl)-β-cyclodextrin Journal of Pharmaceutical and Biomedical Analysis 39 3 2005 572 580
23. F. Van De Manakker, T. Vermonden, C.F. Van Nostrum, and W.E. Hennink Cyclodextrin-based polymeric materials: Synthesis, properties, and pharmaceutical/biomedical applications Biomacromolecules 10 12 2009 3157 3175
24. B. Yang, J. Lin, Y. Chen, and Y. Liu Artemether/hydroxypropyl-β- cyclodextrin host-guest system: Characterization, phase-solubility and inclusion mode Bioorganic and Medicinal Chemistry 17 17 2009 6311 6317
25. J. Zeng, Y. Ren, C. Zhou, S. Yu, and W.H. Chen Preparation and physicochemical characteristics of the complex of edaravone with hydroxypropyl-β-cyclodextrin Carbohydrate Polymers 83 3 2011 1101 1105